Companion Animal Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

The Global market for companion animal diagnostics is expected to expand from USD 3.02 billion in 2025 to USD 4.61 billion by 2031, reflecting a compound annual growth rate (CAGR) of 7.3%. This industry includes a variety of medical devices, testing kits, reagents, and consumable supplies used to identify, track, and treat illnesses in pets like cats and dogs. The sector's upward trajectory is largely fueled by the growing tendency to treat pets as family members, which in turn drives up spending on veterinary services and heightens the focus on preventive healthcare.

Additionally, the rising frequency of infectious and chronic diseases, alongside breakthroughs in diagnostic methods such as molecular testing and point-of-care solutions, plays a major role in this expansion. Highlighting the massive pet population supporting this demand, the American Pet Products Association (APPA) 2023-2024 National Pet Owners Survey reported that more than 65.1 million U.S. households had dogs and over 46.5 million had cats in 2023.

Even with strong growth projections, the market faces a major hurdle due to the high expenses linked to sophisticated diagnostic machinery and specialized testing procedures. This economic obstacle limits the broad implementation of these tools, especially in areas with tighter budgets and within smaller-scale veterinary clinics that may lack extensive capital.

Market Driver

The Global companion animal diagnostics industry is largely driven by rising pet ownership and the growing trend of pet humanization. Because owners increasingly view their pets as cherished family members, they place a higher priority on their overall health, generating greater need for state-of-the-art diagnostic tools. This shift encourages proactive healthcare strategies that emphasize early disease detection and preventive measures rather than merely treating existing conditions. Data from the American Pet Products Association (APPA) 2025 State of the Industry Report, published in March 2025, indicates that 94 million U.S. households had a minimum of one pet in 2024, a notable rise from 82 million the previous year. This growing number of pets creates a broader patient base needing routine exams, health monitoring, and disease screenings, directly boosting the demand for diagnostic instruments, specialized testing, and reagents.

At the same time, a surge in veterinary healthcare spending serves as a major catalyst for market expansion. Motivated by the humanization of their pets, owners are showing a greater readiness to pay for extensive veterinary services, which includes complex diagnostic evaluations. This influx of funding allows veterinary clinics to integrate and employ cutting-edge diagnostic innovations. The 2025 APPA State of the Industry Report noted that U.S. pet owners allocated $41.0 billion toward veterinary care and product purchases in 2024.

These significant financial contributions facilitate the purchase of premium diagnostic machinery, such as sophisticated imaging devices and molecular testing platforms, that improve the speed and precision of medical assessments. Ultimately, this heightened financial dedication to animal health fuels the ongoing growth of the diagnostics sector, supported by the fact that overall U.S. pet industry spending hit $152 billion in 2024 according to the APPA.

Market Challenge

The steep prices of specialized tests and sophisticated diagnostic machinery pose a major obstacle to the expansion of the worldwide companion animal diagnostics industry. Such financial constraints prevent the broad utilization of crucial diagnostic technologies, especially in areas with limited budgets and among smaller veterinary clinics that find large capital expenditures difficult to manage. As a result, the ability of these smaller practices to provide a full spectrum of advanced diagnostic options is diminished, which directly restricts the market's growth by limiting the number of potential users for these high-end products.

The burden of these high expenses also affects pet owners, heavily swaying their choices when veterinarians recommend specific treatments or tests. Based on data from the American Veterinary Medical Association (AVMA) in 2026, 81% of polled veterinarians noticed an increase in client price sensitivity compared to 72% in 2024. Because of this heightened financial caution, diagnostic procedures have become the most commonly declined veterinary services, subsequently dampening the overall demand and market penetration for advanced diagnostic technologies.

Market Trends

A major trend currently shaping the global companion animal diagnostics sector is the transition toward sophisticated genomic and molecular testing, which delivers higher accuracy and quicker identification of complicated ailments. These advanced methodologies allow veterinary professionals to pinpoint specific cancers, genetic vulnerabilities, and infectious agents with exceptional precision.

By recognizing health issues at the molecular stage, veterinarians can implement customized therapies and proactive care strategies that significantly enhance patient outcomes. Demonstrating this potential, VolitionRx Limited announced on January 8, 2026, that clinical data for its Nu.Q® Vet Feline assay showed the test successfully identified more than 80% of feline lymphomas while maintaining 100% specificity. Such reliable performance ultimately builds stronger trust among pet owners regarding the value of high-tech diagnostics.

At the same time, incorporating machine learning and artificial intelligence into diagnostic procedures is transforming the veterinary field through enhanced precision and operational efficiency. Platforms driven by AI can process vast amounts of information from patient histories, laboratory findings, and medical imaging, helping veterinarians spot difficult-to-detect patterns and formulate well-informed medical choices. This technological shift is especially beneficial for tasks that demand quick evaluations and predictive modeling.

By utilizing these smart technologies, veterinary teams can optimize their daily workflows and redirect their focus toward direct patient treatment. A survey by Instinct Science, shared by Today's Veterinary Business Staff on March 19, 2026, revealed that approximately 48% of general veterinary clinics now incorporate AI applications, mostly for administrative tasks and managing medical records. This growing acceptance highlights a wider industry pivot toward intelligent, data-centric diagnostic methodologies.

Key Market Players

• DEXX Laboratories, Inc.
• Zoetis Inc.
• Virbac
• Heska Corporation
• Neogen Corporation
• Bio-Rad Laboratories, Inc.
• INDICAL Bioscience GmbH
• Agrolabo SpA
• ID.vet
• bioMérieux S.A.

Report Scope

In this report, the Global Companion Animal Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Companion Animal Diagnostics Market, By Animal Type:

• Dogs
• Cats
• Horses
• Others

Companion Animal Diagnostics Market, By Technology:

• Clinical Biochemistry
• Clinical Chemistry Analysis
• Glucose Monitoring
• Blood Gas & Electrolyte Analysis
• Immunodiagnostics
• Hematology
• Urinalysis
• Others

Companion Animal Diagnostics Market, By Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Companion Animal Diagnostics Market.

Available Customizations

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.